Evidence map›Paper›PMID 32312600›Full record

GuidelineMedicina intensiva2020

[Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection].

César Cinesi Gómez, Óscar Peñuelas Rodríguez, Manel Luján Torné, Carlos Egea Santaolalla, Juan Fernando Masa Jiménez, Javier García Fernández, José Manuel Carratalá Perales, Sarah Béatrice Heili-Frades, Miquel Ferrer Monreal, José M de Andrés Nilsson and 15 more

Open access · greenAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Medicina intensiva, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. High-flow nasal cannulaTherapeutic advances in respiratory disease
    Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Impact of one year of pandemic on Spanish Intensive Care Units.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Therapeutic prospects of ceRNAs in COVID-19.Frontiers in cellular and infection microbiology · 2022
    Review
  16. Microorganisms · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 1 country.

César Cinesi GómezDirección General de Asistencia Sanitaria, Servicio Murciano de Salud. Director del Máster Oficial en Medicina de Urgencias y Emergencias, Murcia, España.
Óscar Peñuelas RodríguezServicio de Medicina Intensiva y Grandes Quemados, Hospital Universitario de Getafe. CIBER de Enfermedades Respiratorias, CIBERES, Getafe, Madrid, España. Electronic address: openuelas@gmail.com.
Manel Luján TornéServicio de Neumología, Hospital de Sabadell, Corporació Parc Taulí, Universitat Autònoma de Barcelona. Centro de Investigación Biomédica en Red, CIBERES, Sabadell, Barcelona, España.
Carlos Egea SantaolallaUnidad Funcional de Sueño, Hospital Universitario Araba. OSI Araba, Vitoria-Gasteiz, España.
Juan Fernando Masa JiménezServicio de Neumología, Hospital San Pedro de Alcántara. CIBER de Enfermedades Respiratorias (CIBERES). Instituto Universitario de Investigación Biosanitaria de Extremadura (INUBE), Cáceres, España.
Javier García FernándezServicio de Anestesia, Cuidados Críticos Quirúrgicos y Dolor, Hospital Universitario Puerta de Hierro, Madrid, España.
José Manuel Carratalá PeralesServicio de Urgencias, Unidad de Corta Estancia y Hospitalización a Domicilio, Hospital General de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-Fundación FISABIO), Alicante, España.
Sarah Béatrice Heili-FradesUnidad de Neumología, Responsable de la UCIR, Hospital Universitario Fundación Jiménez Díaz. CIBERES, REVA, EMDOS, Madrid, España.
Miquel Ferrer MonrealServei de Pneumologia, Institut Clínic de Respiratori, Hospital Clínic de Barcelona, IDIBAPS, CIBERES (CB06/06/0028), Universitat de Barcelona, Barcelona, España.
José M de Andrés NilssonServicio de Urgencias, Hospital Royo Villanova, Zaragoza, España.
Eva Lista AriasServicio de Urgencias, Parc Taulí Hospital Universitari, Sabadell, Barcelona, España.
Juan Luis Sánchez RocamoraServicio de Urgencias, Hospital General de Villarrobledo, Villarrobledo, Albacete, España.
José Ignacio GarroteServicio de Emergencias GUETS, SESCAM. Coordinador docente Eliance, España.
Miguel J Zamorano SerranoServicio de Urgencias, Hospital Ramón y Cajal, Madrid, España.
Mónica González MartínezUnidad de Sueño y Ventilación, Neumología, Hospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander, España.
Eva Farrero MuñozServei de Pneumologia, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, España.
Olga Mediano San AndrésUnidad del Sueño, Neumología, Hospital Universitario de Guadalajara, Guadalajara, España.
Gemma Rialp CerveraServicio de Medicina Intensiva, Hospital Universitari Son Llàtzer, Palma de Mallorca, España.
Arantxa Mas SerraServei de Medicina Intensiva, Hospital de Sant Joan Despí Moisès Broggi y Hospital General d'Hospitalet, Sant Joan Despí, Barcelona, España.
Gonzalo Hernández MartínezServicio de Medicina Intensiva, Hospital Universitario Virgen de la Salud, Toledo, España.
Candelaria de Haro LópezÁrea de Críticos, Corporació Sanitària i Universitària Parc Taulí. CIBER de Enfermedades Respiratorias (CIBERES). Instituto de Salud Carlos III, Sabadell, Barcelona, España.
Oriol Roca GasServicio de Medicina Intensiva, Hospital Universitario Vall d'Hebron, Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona. CIBER de Enfermedades Respiratorias (CIBERES). Instituto de Salud Carlos III, Barcelona, España.
Ricard Ferrer RocaServicio de Medicina Intensiva, Hospital Universitario Vall d'Hebron. Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Institut de Recerca. CIBER de Enfermedades Respiratorias, CIBERES, Barcelona, España.
Antonio Romero BerrocalServicio de Anestesia y Reanimación, Hospital Universitario Puerta de Hierro, Madrid, España.
Carlos Ferrando OrtolaÁrea de Cuidados Intensivos Quirúrgicos, Servicio de Anestesia y Cuidados Intensivos, Hospital Clínic, Barcelona, España.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESSociedad Española de Cuidados Intensivos Pediátricos · ESBellvitge University Hospital · ESCorporació Sanitària Parc Taulí · ESDeleted InstitutionHospital de Sant Joan Despí Moisès Broggi · ESHospital Royo Villanova · ESHospital Son Llatzer · ESHospital Universitario Araba · ESHospital Universitario de Getafe · ESHospital Universitario de Guadalajara · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Ramón y Cajal · ESHospital Virgen de la Salud · ESInstituto de Investigación Marqués de Valdecilla · ESInstituto de investigación sanitaria y biomédica de AlicanteInstituto de Salud Carlos III · ESServicio de Salud de Castilla La Mancha · ESServicio Murciano de Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.

Indexed as

BetacoronavirusPandemicsAcute DiseaseAdultAerosolsCoronavirus InfectionsCOVID-19Cross InfectionDisease ManagementEquipment ContaminationEquipment DesignHumansInfectious Disease Transmission, Patient-to-ProfessionalInfectious Disease Transmission, Professional-to-PatientNoninvasive VentilationOxygen Inhalation TherapyAerosolsAerosol-generating proceduresControl de infecciónHigh-flow nasal therapyInfection controlNon-invasive mechanical ventilationProcedimientos generadores de aerosolesTerapia nasal de alto flujoVentilación mecánica no invasiva

Identifiers

PMID32312600
PMCPMC7270576
OpenAlexW3027348139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.